Skip to Content

Moxeza Approval History

  • FDA approved: Yes (First approved November 19th, 2010)
  • Brand name: Moxeza
  • Generic name: moxifloxacin
  • Dosage form: Ophthalmic Solution
  • Company: Alcon, Inc.
  • Treatment for: Conjunctivitis, Bacterial

Moxeza (moxifloxacin hydrochloride ophthalmic solution) is a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis.

Development History and FDA Approval Process for Moxeza

Nov 19, 2010Approval FDA Approves Moxeza for Bacterial Conjunctivitis

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.